Skip to main content

Table 2 Expected Cost and Effectiveness of Continuous Glucose Monitoring (CGM) and Self-Monitoring of Blood Glucose (SMBG)

From: Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes

Strategy

Expected Cost in 2007 $US (range)*

Expected Effectiveness QALYs (range)*

Incremental cost-effectiveness ratio (ICER)

SMBG

470,583 (397,782 - 550,598)

10.289 (9.615 - 10.957)

 

CGM and SMBG

494,135 (420,381 - 571,631)

10.812 (9.894 - 11.887)

US $45,033/QALY

  1. *95% credible ranges based on the results from the 10,000 Monte Carlo simulations